What is VIP used for in research?

Research covers chronic inflammation, pulmonary function, immune modulation, and notably chronic inflammatory response syndrome (CIRS). Sarcoidosis and pulmonary hypertension also have substantial clinical literature. For research purposes only.

Why is VIP used specifically in CIRS research?

Chronic Inflammatory Response Syndrome disrupts the HPA axis and produces persistent inflammation. VIP's role in normalizing neuroendocrine and immune signaling is why Shoemaker's research protocols use it as a late-stage intervention after biotoxin exposure is resolved. For research purposes only.

How does VIP compare to Thymosin Alpha-1 for immune research?

Different mechanisms. TA-1 works on T-cell maturation; VIP works broadly on inflammatory signaling and immune-neuroendocrine crosstalk. They can be studied in parallel rather than as substitutes. For research purposes only.

VIP - NOVIS

Research Parameters

Typical Dose Range: Research (intranasal): 50 mcg 4 times daily (standard Shoemaker protocol)
Half-Life: ~2 minutes (plasma); longer in tissue
Administration Route: Intranasal, Subcutaneous, Inhaled

Dosing information is for research purposes only and has not been evaluated by the FDA.

VIP is what the research points toward for the chronic inflammation that doesn't show up on standard bloodwork. The kind that follows mold exposure, tick-borne illness, or post-viral syndromes. If you've gone through the functional medicine rabbit hole and encountered CIRS (Chronic Inflammatory Response Syndrome), VIP is the peptide at the end of Shoemaker's protocol, used as a late-stage intervention once other biomarkers have been normalized.

Beyond CIRS, VIP has a substantial clinical research literature in sarcoidosis and pulmonary hypertension, and it's being studied for immune modulation and pulmonary function broadly. The reason it's so widely researched: VIP functions simultaneously as a neurotransmitter, a hormone, and an immunomodulator, which is why it appears across so many different research areas.

For research purposes only.

Mechanism of Action

VIP is a 28-amino-acid peptide first isolated from small intestine but active throughout the body (nervous system, immune tissue, cardiovascular system). Its receptors (VPAC1, VPAC2) are widely distributed, and the tissue-specific distribution of those receptors explains why downstream effects vary dramatically depending on where VIP reaches. Plasma half-life is very short; the active effect happens at receptor sites.

Citations

Vasoactive Intestinal Peptide (VIP) in the Nervous System and Its Role in Neuromodulation and Inflammation (2019)

Frequently Asked Questions

What is VIP used for in research?: Research covers chronic inflammation, pulmonary function, immune modulation, and notably chronic inflammatory response syndrome (CIRS). Sarcoidosis and pulmonary hypertension also have substantial clinical literature. For research purposes only.
Why is VIP used specifically in CIRS research?: Chronic Inflammatory Response Syndrome disrupts the HPA axis and produces persistent inflammation. VIP's role in normalizing neuroendocrine and immune signaling is why Shoemaker's research protocols use it as a late-stage intervention after biotoxin exposure is resolved. For research purposes only.
How does VIP compare to Thymosin Alpha-1 for immune research?: Different mechanisms. TA-1 works on T-cell maturation; VIP works broadly on inflammatory signaling and immune-neuroendocrine crosstalk. They can be studied in parallel rather than as substitutes. For research purposes only.

Related Peptides

BPC-157 + TB-500 Stack BPC-157 + TB-500 Recovery Stack Protocol LL-37 LL-37 (Cathelicidin Antimicrobial Peptide) NAD+ NAD+ (Nicotinamide Adenine Dinucleotide)